TNF and preeclampsia: Bioprinted organoids were used for a drug screening with aspirin (0.5 mM) or metformin (0.5 mM) to investigate their ability to ameliorate inflammation-induced (TNFα 20 ng/ml) trophoblast dysfunction in the context of preeclampsia (Fig. 4a).